2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- has been researched along with 1-methyl-4-phenylpyridinium in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sonsalla, PK; Staal, RG | 1 |
1 other study(ies) available for 2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- and 1-methyl-4-phenylpyridinium
| Article | Year |
|---|---|
Inhibition of brain vesicular monoamine transporter (VMAT2) enhances 1-methyl-4-phenylpyridinium neurotoxicity in vivo in rat striata.
Topics: 1-Methyl-4-phenylpyridinium; 2H-Benzo(a)quinolizin-2-ol, 2-Ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-; Animals; Brain Chemistry; Dose-Response Relationship, Drug; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Microdialysis; Neostriatum; Neuropeptides; Neurotoxins; Neurotransmitter Agents; Rats; Rats, Sprague-Dawley; Species Specificity; Synaptic Vesicles; Time Factors; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2000 |